DK1131113T3 - Bioaktive proteser af ledende materiale belagt med en polymer og et stof med immunosuppressions-, antistenose- og antitromboseegenskaber - Google Patents

Bioaktive proteser af ledende materiale belagt med en polymer og et stof med immunosuppressions-, antistenose- og antitromboseegenskaber

Info

Publication number
DK1131113T3
DK1131113T3 DK99972115T DK99972115T DK1131113T3 DK 1131113 T3 DK1131113 T3 DK 1131113T3 DK 99972115 T DK99972115 T DK 99972115T DK 99972115 T DK99972115 T DK 99972115T DK 1131113 T3 DK1131113 T3 DK 1131113T3
Authority
DK
Denmark
Prior art keywords
antistinosis
immunosuppression
polymer
substance
conductive material
Prior art date
Application number
DK99972115T
Other languages
English (en)
Inventor
Guy Deniau
Moel Alain Le
Natacha Betz
Christophe Bureau
Charles Baquey
Gerard Deleris
Werner Haberbosch
Original Assignee
Commissariat Energie Atomique
Inst Nat Sante Rech Med
Kerckhoff Klinik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique, Inst Nat Sante Rech Med, Kerckhoff Klinik Gmbh filed Critical Commissariat Energie Atomique
Application granted granted Critical
Publication of DK1131113T3 publication Critical patent/DK1131113T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005Use of materials characterised by their function or physical properties
    • A61L33/0011Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0029Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/258Genetic materials, DNA, RNA, genes, vectors, e.g. plasmids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406Antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41Anti-inflammatory agents, e.g. NSAIDs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/18Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99972115T 1998-11-16 1999-11-15 Bioaktive proteser af ledende materiale belagt med en polymer og et stof med immunosuppressions-, antistenose- og antitromboseegenskaber DK1131113T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9814351A FR2785812B1 (fr) 1998-11-16 1998-11-16 Protheses bioactives, notamment a proprietes immunosuppressives, antistenose et antithrombose, et leur fabrication

Publications (1)

Publication Number Publication Date
DK1131113T3 true DK1131113T3 (da) 2005-11-14

Family

ID=9532761

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99972115T DK1131113T3 (da) 1998-11-16 1999-11-15 Bioaktive proteser af ledende materiale belagt med en polymer og et stof med immunosuppressions-, antistenose- og antitromboseegenskaber

Country Status (14)

Country Link
US (1) US6517858B1 (da)
EP (1) EP1131113B1 (da)
JP (1) JP4294873B2 (da)
AT (1) ATE299719T1 (da)
AU (1) AU769176B2 (da)
CA (1) CA2349930C (da)
DE (1) DE69926255T2 (da)
DK (1) DK1131113T3 (da)
ES (1) ES2246592T3 (da)
FR (1) FR2785812B1 (da)
IL (2) IL143086A0 (da)
MX (1) MXPA01004898A (da)
PT (1) PT1131113E (da)
WO (1) WO2000029043A1 (da)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7807211B2 (en) 1999-09-03 2010-10-05 Advanced Cardiovascular Systems, Inc. Thermal treatment of an implantable medical device
US8236048B2 (en) 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
US20050002986A1 (en) * 2000-05-12 2005-01-06 Robert Falotico Drug/drug delivery systems for the prevention and treatment of vascular disease
US6776796B2 (en) 2000-05-12 2004-08-17 Cordis Corportation Antiinflammatory drug and delivery device
US20070276476A1 (en) 2000-09-29 2007-11-29 Llanos Gerard H Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon
JP5100951B2 (ja) 2000-09-29 2012-12-19 コーディス・コーポレイション 被覆医用器具
FR2821575B1 (fr) * 2001-03-02 2003-10-24 Commissariat Energie Atomique Procede de greffage organique localise sans masque sur des protions conductrices ou semiconductrices de surfaces composites
US20020163504A1 (en) * 2001-03-13 2002-11-07 Pallakoff Matthew G. Hand-held device that supports fast text typing
US7247313B2 (en) * 2001-06-27 2007-07-24 Advanced Cardiovascular Systems, Inc. Polyacrylates coatings for implantable medical devices
FR2829046B1 (fr) 2001-08-28 2005-01-14 Commissariat Energie Atomique Procede de greffage et de croissance d'un film organique conducteur sur une surface
US8303651B1 (en) 2001-09-07 2012-11-06 Advanced Cardiovascular Systems, Inc. Polymeric coating for reducing the rate of release of a therapeutic substance from a stent
US7153656B2 (en) * 2001-09-11 2006-12-26 Los Alamos National Security, Llc Nucleic acid sequence detection using multiplexed oligonucleotide PCR
US20030208166A1 (en) * 2002-05-06 2003-11-06 Schwartz Anthony H. Implantable device with free-flowing exit and uses thereof
CA2494364C (en) 2002-08-22 2009-08-25 Victhom Human Bionics, Inc. Actuated leg prosthesis for above-knee amputees
US7736394B2 (en) * 2002-08-22 2010-06-15 Victhom Human Bionics Inc. Actuated prosthesis for amputees
US20050095267A1 (en) * 2002-12-04 2005-05-05 Todd Campbell Nanoparticle-based controlled release polymer coatings for medical implants
FR2851181B1 (fr) * 2003-02-17 2006-05-26 Commissariat Energie Atomique Procede de revetement d'une surface
FR2851258B1 (fr) * 2003-02-17 2007-03-30 Commissariat Energie Atomique Procede de revetement d'une surface, fabrication d'interconnexion en microelectronique utilisant ce procede, et circuits integres
WO2004075943A1 (en) * 2003-02-28 2004-09-10 Biointeractions Ltd. Polymeric network system for medical devices and methods of use
ES2318312T3 (es) * 2003-03-31 2009-05-01 Memry Corporation Dispositivos medicos que presentan propiedades de elucion de farmacos y procedimientos de fabricacion de los mismos.
US6923996B2 (en) * 2003-05-06 2005-08-02 Scimed Life Systems, Inc. Processes for producing polymer coatings for release of therapeutic agent
US7279174B2 (en) 2003-05-08 2007-10-09 Advanced Cardiovascular Systems, Inc. Stent coatings comprising hydrophilic additives
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
US7815689B2 (en) 2003-11-18 2010-10-19 Victhom Human Bionics Inc. Instrumented prosthetic foot
US9114198B2 (en) 2003-11-19 2015-08-25 Advanced Cardiovascular Systems, Inc. Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
JP4618997B2 (ja) * 2003-12-09 2011-01-26 テルモ株式会社 ステントおよびその製造方法
US7896927B2 (en) 2004-02-12 2011-03-01 össur hf. Systems and methods for actuating a prosthetic ankle based on a relaxed position
US8057550B2 (en) 2004-02-12 2011-11-15 össur hf. Transfemoral prosthetic systems and methods for operating the same
US7563780B1 (en) * 2004-06-18 2009-07-21 Advanced Cardiovascular Systems, Inc. Heparin prodrugs and drug delivery stents formed therefrom
FR2873016B1 (fr) 2004-07-15 2006-09-29 Pierre Marcel Bourgogne Protheses vasculaires artificielles delivrant en permanence des produits actifs empechant toute stenose, thrombose, proliferation cellulaire, etc.. d'acces aise permanent pour toute intervention
US20060013853A1 (en) * 2004-07-19 2006-01-19 Richard Robert E Medical devices having conductive substrate and covalently bonded coating layer
US8029563B2 (en) 2004-11-29 2011-10-04 Gore Enterprise Holdings, Inc. Implantable devices with reduced needle puncture site leakage
EP2037981B1 (en) * 2006-06-13 2019-05-08 Alchimedics Drug eluting stent with a biodegradable release layer attached with an electro-grafted primer coating
US9028859B2 (en) 2006-07-07 2015-05-12 Advanced Cardiovascular Systems, Inc. Phase-separated block copolymer coatings for implantable medical devices
US20080042662A1 (en) * 2006-08-16 2008-02-21 George Abraham Method For Detecting Stent Coating Defects
WO2008080231A1 (en) 2007-01-05 2008-07-10 Victhom Human Bionics Inc. Joint actuation mechanism for a prosthetic and/or orthotic device having a compliant transmission
EP2104476B1 (en) * 2007-01-05 2016-01-06 Victhom Human Bionics Inc. High torque active mechanism for orthotic devices
WO2008086629A1 (en) 2007-01-19 2008-07-24 Victhom Human Bionics Inc. Reactive layer control system for prosthetic and orthotic devices
US10265407B2 (en) 2007-02-15 2019-04-23 Yale University Modular nanodevices for smart adaptable vaccines
US20100151436A1 (en) * 2007-03-02 2010-06-17 Fong Peter M Methods for Ex Vivo Administration of Drugs to Grafts Using Polymeric Nanoparticles
US8343212B2 (en) * 2007-05-15 2013-01-01 Biotectix, LLC Polymer coatings on medical devices
US20090076591A1 (en) * 2007-09-19 2009-03-19 Boston Scientific Scimed, Inc. Stent Design Allowing Extended Release of Drug and/or Enhanced Adhesion of Polymer to OD Surface
US7863387B2 (en) 2007-10-25 2011-01-04 Boston Scientific Scimed, Inc. Dehydrofluorination and surface modification of fluoropolymers for drug delivery applications
US7833266B2 (en) * 2007-11-28 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment
JP2011509156A (ja) * 2008-01-08 2011-03-24 イェール ユニバーシティ 血管移植片の開存性を促進するための組成物および方法
EP2249893A2 (en) * 2008-02-01 2010-11-17 Boston Scientific Scimed, Inc. Drug-coated medical devices for differential drug release
US7951193B2 (en) * 2008-07-23 2011-05-31 Boston Scientific Scimed, Inc. Drug-eluting stent
US9060884B2 (en) 2011-05-03 2015-06-23 Victhom Human Bionics Inc. Impedance simulating motion controller for orthotic and prosthetic applications
US10543109B2 (en) 2011-11-11 2020-01-28 Össur Iceland Ehf Prosthetic device and method with compliant linking member and actuating linking member
US9532877B2 (en) 2011-11-11 2017-01-03 Springactive, Inc. Robotic device and method of using a parallel mechanism
US9044346B2 (en) 2012-03-29 2015-06-02 össur hf Powered prosthetic hip joint
EP2841098A4 (en) 2012-04-23 2016-03-02 Allertein Therapeutics Llc NANOPARTICLES FOR THE TREATMENT OF ALLERGIES
WO2014133975A1 (en) 2013-02-26 2014-09-04 össur hf Prosthetic foot with enhanced stability and elastic energy return
EP2967920B1 (en) 2013-03-14 2021-04-21 Ossur Hf Prosthetic ankle: a method of controlling based on adaptation to speed
EP2981285B1 (en) 2013-04-03 2020-06-03 N-Fold Llc Novel nanoparticle compositions
US9814560B2 (en) 2013-12-05 2017-11-14 W. L. Gore & Associates, Inc. Tapered implantable device and methods for making such devices
WO2015157723A1 (en) 2014-04-11 2015-10-15 össur hf Prosthetic foot with removable flexible members
WO2016053621A1 (en) * 2014-09-16 2016-04-07 Sri International Affinity reagent and catalyst discovery though fiber-optic array scanning technology
CN105031745B (zh) * 2015-05-08 2018-10-19 上海起励生物技术服务中心 一种用聚合物包裹金属假体的骨科内植入物
BR112017025950A2 (pt) 2015-06-05 2018-08-14 W. L. Gore & Associates, Inc. ?prótese implantável de baixo sangramento com um afunilador?
JP6957468B2 (ja) 2015-12-11 2021-11-02 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル 最適化された患者特異的組織操作血管移植片のためのシステムおよび方法
EP3590343A1 (fr) * 2018-07-04 2020-01-08 Centre National de la Recherche Scientifique Materiaux et dispositifs biocides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826678A (en) * 1972-06-06 1974-07-30 Atomic Energy Commission Method for preparation of biocompatible and biofunctional materials and product thereof
US4879135A (en) * 1984-07-23 1989-11-07 University Of Medicine And Dentistry Of New Jersey Drug bonded prosthesis and process for producing same
US5344455A (en) * 1992-10-30 1994-09-06 Medtronic, Inc. Graft polymer articles having bioactive surfaces
US6174326B1 (en) 1996-09-25 2001-01-16 Terumo Kabushiki Kaisha Radiopaque, antithrombogenic stent and method for its production
AU4572097A (en) * 1996-10-15 1998-05-11 Ebara Corporation Bioactive polymer product
US6776792B1 (en) * 1997-04-24 2004-08-17 Advanced Cardiovascular Systems Inc. Coated endovascular stent
US6254634B1 (en) * 1998-06-10 2001-07-03 Surmodics, Inc. Coating compositions
US6248127B1 (en) * 1998-08-21 2001-06-19 Medtronic Ave, Inc. Thromboresistant coated medical device

Also Published As

Publication number Publication date
US6517858B1 (en) 2003-02-11
ES2246592T3 (es) 2006-02-16
AU1168100A (en) 2000-06-05
FR2785812A1 (fr) 2000-05-19
DE69926255D1 (de) 2005-08-25
JP4294873B2 (ja) 2009-07-15
IL143086A (en) 2006-08-20
WO2000029043A1 (fr) 2000-05-25
ATE299719T1 (de) 2005-08-15
PT1131113E (pt) 2005-11-30
CA2349930A1 (fr) 2000-05-25
CA2349930C (fr) 2007-06-26
AU769176B2 (en) 2004-01-15
EP1131113A1 (fr) 2001-09-12
JP2002529203A (ja) 2002-09-10
FR2785812B1 (fr) 2002-11-29
DE69926255T2 (de) 2006-04-20
EP1131113B1 (fr) 2005-07-20
MXPA01004898A (es) 2007-08-21
IL143086A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
DK1131113T3 (da) Bioaktive proteser af ledende materiale belagt med en polymer og et stof med immunosuppressions-, antistenose- og antitromboseegenskaber
CA2366665A1 (en) Polymer coated stent
BR0213279A (pt) Revestimento de stents para impedir a restenose
DE69913342D1 (de) Stents mit diamantartiger beschichtung
DE69913198D1 (de) Selbstexpandierende prothese mit biokompatibler beschichtung
WO2002074194A3 (en) Stent with medicated multi-layer hydrid polymer coating
AU7708300A (en) Delivery system for self-expanding stents and grafts
WO2006029375A3 (en) Stents with metallic covers
WO2004030678A3 (en) Polymer compositions containing bioactive agents and methods for their use
DK0821648T3 (da) Fremgangsmåde til fremstilling af radiært udvidelige PTFE-tapeforstærkede karimplantater
NO982052L (no) Selvekspanderende endoluminalt stent-transplantat
ATE329553T1 (de) Prothesenverbundlager und herstellungsverfahren
WO2004075781A3 (en) Bioactive stents and methods for use thereof
PT1409036E (pt) Dispositivos protéticos com superfícies de zircónio oxidado em contacto com superfícies de polietileno reticulado
DE60031381D1 (de) Eine einzige punktion erfordendes entfaltungssystem für ein gefässimplantat mit verzweigung
WO1999016416A3 (de) Beschichtete medizinische implantate, verfahren zu ihrer herstellung und ihre verwendung zur restenoseprophylaxe
DE19834956B9 (de) Stützprothese (Stent)
WO2002007646A3 (en) Artificial vascular grafts, and methods of producing and using same
AU2078599A (en) Self-expanding bifurcation stent and delivery system
WO2000054822A3 (en) Biocompatible endoprostheses
DE69841041D1 (de) Stent beschichtet mit dna
WO1998058680A3 (de) Mit fluoralkylgruppen beschichtete stents
WO1997049434A3 (en) Heparinized medical devices containing heparin-binding growth factor conjugates
AU4606199A (en) Superficial implant and surface coating for stents and other implants
ITPI950005A0 (it) Metodo per il rivestimento di protesi vascolari con polimeri sintetici biodegradabili e bioriassorbibili, loro miscele o ipns reti polimeriche interpenetrate